| Revenue growth | 32% YoY growth in FY26 to ₹998.8cr. |
|---|---|
| Margins | EBITDA margins improved 100bps to 23.8%; PAT margins up 310bps. |
| Demand visibility | Strong; dialysis is non-discretionary with projected 13% CAGR market growth. |
| Management confidence | High; citing India platform's success in driving international growth. |
Growth
FY26 revenue up 32% to ₹998.8cr; Adjusted EBITDA grew 37% to ₹238.2cr; Adjusted PAT surged 74.6% to ₹128.3cr.
Outlook
Medium-term revenue CAGR guidance of 15-20%; plans to add 40-50 clinics in India and 10-15 in Philippines annually.
Risks
Regulatory complexities in international markets; potential non-renewal of PPP contracts like Uttarakhand; high working capital requirements.
Earnings Call filed with NSE, NSE: NEPHROPLUS. Summary written with AI assistance from the document.
Nephrocare Health Services Ltd: key numbers
- Share price
- ₹643.00
- Market cap
- ₹6,452 Cr
- Revenue (annual)
- ₹998.8 Cr
- Net profit (annual)
- ₹76.84 Cr
- P/E (TTM)
- 75.8×Sector 53.1×
- Promoter holding
- 63.85%+0.00% QoQ
- FII holding
- 8.78%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Nephrocare Health Services Ltd
All →Nephrocare Health Services Credit Rating
India Ratings upgraded Nephrocare Health Services' long-term bank loan facilities to IND AA-/Stable. The agency also affirmed the company's short-term credit ratings.
Nephrocare Health Services Merger & Restructuring
Nephrocare Health Services Ltd announced the rationalisation and consolidation of its step-down subsidiaries in the Philippines. This internal reorganization streamlines the group's existing structure.
Nephrocare Health Services Merger & Restructuring Worth ₹10.25 Cr
Nephrocare's Philippines subsidiary acquired a dialysis center from Renal One Dialysis Corp for ≈₹10.25 Cr. The asset transfer expands the company's dialysis network.
- Value
- ₹10.25 Cr
- dialysis center acquired
- 1 dialysis centers
Nephrocare Health Services Acquisition Worth ₹10.25 Cr
Nephrocare's Philippines subsidiary is acquiring a dialysis center from Renal One Dialysis Corp. for a consideration of ₹10.25 crore.
- Value
- ₹10.25 Cr
Nephrocare Health Services Employee Stock Options
Nephrocare Health Services granted 4,01,362 employee stock options at an exercise price of ₹230 per share. These options are issued under the NephroPlus Employee Stock Option Scheme 2026.
Nephrocare Health Services Acquisition Worth ₹11.63 Cr
Nephroplus Health Services Kazakhstan LLP will acquire a 100% stake in 'Dialysis Center Almaty' LLP for approximately ₹11.64 Crore to expand its international dialysis network.
- Value
- ₹11.63 Cr